SIRA Healthcare has begun site selection for a second diagnostic centre in East Africa, with an opening targeted for 2027.

The centre will be a stand-alone molecular imaging facility replicating the PET-CT wing at Rosina Diagnostic Center in Nairobi, served by a regional cyclotron partnership for isotope supply. It will run on the same operating system, the same clinical protocols and the same referral relationships as Rosina, with radiology reported centrally from Nairobi.

The centre is the first step of the group’s diagnostic network expansion, which is open to investors as a single platform position rather than a series of single-centre investments.